<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">Data about COVID-19 in patients with diabetes is limited at present. Diabetes was present in 42.3% of 26 fatalities due to COVID-19 in Wuhan, China [
 <xref rid="bib8" ref-type="bibr">8</xref>]. In a study in 140 patients with COVID-19 in Wuhan, China, diabetes was not a risk factor for severe disease course [
 <xref rid="bib9" ref-type="bibr">9</xref>]. However, another study in 150 patients (68 deaths and 82 recovered patients) in Wuhan showed that the number of co-morbidities to be a significant predictor of mortality [
 <xref rid="bib10" ref-type="bibr">10</xref>]. Analysis of 11 studies regarding laboratory abnormalities in patients with COVID-19 did not mention raised blood glucose or diabetes as predictor of severe disease [
 <xref rid="bib11" ref-type="bibr">11</xref>]. Notwithstanding these small series, a report of 72,314 cases of COVID-19 published by Chinese Centre for Disease Control and Prevention showed increased mortality in people with diabetes (2.3%, overall and 7.3%, patients with diabetes) [
 <xref rid="bib12" ref-type="bibr">12</xref>].
</p>
